|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Artemisinin enhances heme-catalysed oxidation of lipid membranes显示文摘 | Berman P A Adams P A | 1997 | Free Radic Biol Med1997，22，7： | 1 |
| 2 | Effect of tamoxifen on cell lines displaying the multidrug-resistant phenotype显示文摘 | Berman E Adams M Duigou-Osterndorf R | 1991 | Blood1991，77，4： | 1 |
| 3 | Role of cardiac magnetic resonance imaging in the diagnosis and management of COVID-19 related myocarditis: Clinical and imaging considerations显示文摘There is a growing evidence of cardiovascular complications in coronavirusdisease 2019 (COVID-19) patients. As evidence accumulated of COVID-19 mediatedinflammatory effects on the myocardium, substantial attention has beendirected towards cardiovascular imaging modalities that facilitate this diagnosis.Cardiac magnetic resonance imaging (CMRI) is the gold standard for thedetection of structural and functional myocardial alterations and its role inidentifying patients with COVID-19 mediated cardiac injury is growing. Despiteits utility in the diagnosis of myocardial injury in this population, CMRI’s impacton patient management is still evolving. This review provides a framework for theuse of CMRI in diagnosis and management of COVID-19 patients from theperspective of a cardiologist. We review the role of CMRI in the management ofboth the acutely and remotely COVID-19 infected patient. We discuss patientselection for this imaging modality;T1, T2, and late gadolinium enhancementimaging techniques;and previously described CMRI findings in other cardiomyopathieswith potential implications in COVID-19 recovered patients. | Lavannya Atri Michael Morgan Sean Harrell Wael AlJaroudi Adam E Berman | 2021 | World Journal of Radiology2021，13，9： | 1 |
| 4 | Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial显示文摘 | Raj R Makkar Rachel R Smith Ke Cheng Konstantinos Malliaras Louise EJ Thomson Daniel Berman Lawrence SC Czer Linda Marbán Adam Mendizabal Peter V Johnston Stuart D Russell Karl H Schuleri Albert C Lardo Gary Gerstenblith Eduardo Marbán | 2012 | The Lancet2012，，9819： | 1 |
| 5 | Outcome of a Workshop on Applications of Protein Models in Biomedical Research显示文摘 | Torsten Schwede Andrej Sali Barry Honig Michael Levitt Helen M. Berman David Jones Steven E. Brenner Stephen K. Burley Rhiju Das Nikolay V. Dokholyan Roland L. Dunbrack Krzysztof Fidelis Andras Fiser Adam Godzik Yuanpeng Janet Huang Christine Humblet Matt | 2009 | Structure2009，，2： | 1 |
| 6 | Artemisinin enhances heme- catalysed oxidation of lipid membranes 显示文摘 | BERMAN P A ADAMS P A | 1997 | Free Radic Biol Med1997，22，7： | 1 |
| 7 | Artemisinin enhances heme-catalysed oxidation of lipid membranes 显示文摘 | Adams PA | 1997 | Free Radic Biol Med1997，22，： | 1 |
| 8 | Artemisinin enhances heme-catalysed oxidation of artemisinin (qinghaosu) 显示文摘 | Berman P A Adams P A | 1997 | Biochem Pharmacol1997，22，： | 1 |
| 9 | Artemisinin enhances heme-catalysed oxidation of lipid membranes显示文摘 | Berman PA Adams PA | 1997 | Free Radic Biol Med1997，22，7： | 1 |
| 10 | COVID-19 vaccine-associated myocarditis显示文摘Myocarditis is now recognized as a rare complication of coronavirus disease 2019(COVID-19)mRNA vaccination,particularly in adolescent and young adult males.Since the authorization of the Pfizer-BioNTech^(TM)and Moderna^(TM)mRNA vaccines targeting the severe acute respiratory syndrome coronavirus-2(SARSCoV-2)spike protein,the Centers for Disease Control and Prevention(CDC)has reported 1175 confirmed cases of myocarditis after COVID-19 vaccination in individuals ages 30 years and younger as of January 2022.According to CDC data in June 2021,the incidence of vaccine-mediated myocarditis in males ages 12-29 years old was estimated to be 40.6 cases per million second doses of COVID-19 mRNA vaccination administered.Individuals with cases of COVID-19 vaccinemediated myocarditis typically present with acute chest pain and elevated serum troponin levels,often within one week of receiving the second dose of mRNA COVID-19 vaccination.Most cases follow a benign clinical course with prompt resolution of symptoms.Proposed mechanisms of COVID-19 vaccine myocarditis include molecular mimicry between SARS-CoV-2 spike protein and self-antigens and the triggering of preexisting dysregulated immune pathways in predisposed individuals.The higher incidence of COVID-19 vaccine myocarditis in young males may be explained by testosterone and its role in modulating the immune response in myocarditis.There is limited data on long-term outcomes in these cases given the recency of their occurrence.The CDC continues to recommend COVID-19 vaccination for everyone 5 years of age and older given the greater risk of serious complications related to natural COVID-19 infection including hospitalization,multisystem organ dysfunction,and death.Further study is needed to better understand the immunopathology and long-term outcomes behind COVID-19 mRNA vaccine-mediated myocarditis. | Michael C Morgan Lavannya Atri Sean Harrell Wael Al-Jaroudi Adam Berman | 2022 | World Journal of Cardiology2022，14，7： | 1 |
| 11 | Artemisinin enhances heme-catalysed oxidation of lipid membranes显示文摘 | Berman PA Adams PA | 1997 | Free Radic Biol Med1997，22，7： | 1 |
| 12 | Effect of tamoxifen on cell line displaying multidrug resistant phenotype显示文摘 | Berman E Adam M Duigou-osterndorf R | 1991 | Blood1991，77，4： | 1 |
| 13 | Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial显示文摘 | Raj R Makkar Rachel R Smith Ke Cheng Konstantinos Malliaras Louise EJ Thomson Daniel Berman Lawrence SC Czer Linda Marbán Adam Mendizabal Peter V Johnston Stuart D Russell Karl H Schuleri Albert C Lardo Gary Gerstenblith Eduardo Marbán | 2012 | 2012 (9819)2012，，9819： | 1 |
| 14 | Can peak systolic velocities be used for prediction of stroke in sickle cell anemia?显示文摘 | Anne Jones Suzanne Granger Don Brambilla Dianne Gallagher Elliott Vichinsky Gerald Woods Brian Berman Steve Roach Fenwick Nichols Robert J. Adams | 2005 | Pediatric Radiology2005，，1： | 1 |
| 15 | Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions显示文摘 | Charles H. Pegelow Robert J. Adams Virgil McKie Miguel Abboud Brian Berman Scott T. Miller Nancy Olivieri Elliott Vichinsky Winfred Wang Donald Brambilla | 1995 | The Journal of Pediatrics1995，，6： | 1 |
| 16 | Artemisinin enhances heme-catalysed oxidation of lipid membranes显示文摘 | BERMAN P A ADAMS P A | 1997 | Free Radic Biol Med1997，22，： | 1 |
| 17 | Artemisinin enhances heme-catalysed oxidation of lipid membranes显示文摘 | Adams PA | 1997 | Free Rad Biol Med1997，22，： | 1 |
| 18 | Artemisinin Enhances Heme-catalysed Oxidation of Lipid Membranes显示文摘 | Berman P A Adams P A | 1997 | Free Medic Biol Med1997，22，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员